Analysts flag potential capital raises and dividend cuts as insurers balance profitability with rating‑agency solvency tests

Analysts flag potential capital raises and dividend cuts as insurers balance profitability with rating‑agency solvency tests

Who: Financial analysts, rating agencies and senior executives at major insurers. What: Warnings that some carriers may need to raise capital or pare shareholder payouts to satisfy solvency tests while preserving underwriting profits. When: As of early 2026, following 2024–25 trends in claims inflation and post‑pandemic litigation dynamics. Where: Major insurance markets in the United States, the United Kingdom and continental Europe (with implications for Canada, Australia and other developed markets). Why: Persistently elevated claims inflation — including growing “nuclear” jury verdicts in liability lines — combined with softer commercial pricing in parts of the market, higher reinsurance attachment points and the timing of regulatory and rating‑agency stress tests is compressing insurers’ flexibility to fund dividends and buybacks without eroding solvency buffers. (insurancejournal.com)

Insurance companies in advanced markets enter 2026 with operating results that, on aggregate, look healthier than a few years ago: premium growth and underwriting gains improved in 2025 even as reserve strengthening continued in some lines. But analysts and rating agencies say the combination of elevated claims inflation, acute liability exposure in the United States and the calendar of solvency reviews and internal stress tests means boards may have to choose between shareholder distributions and shoring up capital via debt or equity. The trade‑off has already surfaced in public filings and analyst notes: some groups have issued subordinated debt and contingent capital to preserve solvency ratios even while signalling continued dividend guidance; others have held back on buybacks or signalled tighter capital allocation if reserves widen. (quiverquant.com)

Drivers: claims inflation, litigation trends and reinsurance dynamics

The most immediate pressure cited by analysts is claims inflation — the tendency for insured losses to rise faster than headline consumer price measures because of higher medical and repair costs, litigation awards and settlement values. Industry studies and reinsurer analyses point to a meaningful acceleration in large liability awards: one sector analysis documented a sharp increase in “nuclear verdicts” (jury awards exceeding $10 million), with 135 such awards in 2024 totaling roughly $31.3 billion and a large jump in multi‑hundred‑million verdicts. Those trends feed higher loss severity, particularly in commercial auto, general liability and medical malpractice lines. (insurancebusinessmag.com)

“Claims inflation exceeded consumer price index inflation in recent years and will remain the main concern for European primary non‑life insurers,” S&P Global Ratings wrote in its mid‑year 2025 outlook, highlighting that motor and repair cost inflation in particular has forced marked pricing moves in some markets while others lag. (insurancejournal.com)

At the same time, reinsurance markets and attachment points have not returned to the deep softness of pre‑2019; reinsurers remain disciplined on large catastrophe layers, and some reinsurers have raised prices or limited capacity in certain geographies. That combination — higher claim severity and only partially easing reinsurance costs — reduces insurers’ room to absorb adverse outcomes inside their own balance sheets. Rating agencies and bank analysts model those stresses explicitly in their capital tests. (beinsure.com)

What the numbers show (industry‑level context)

The U.S. property‑casualty industry reported marked underwriting improvement in 2025, with net written premiums rising and the industry combined ratio improving into the mid‑90s, according to a sector compilation published in early February 2026. Policyholders’ surplus has increased, reflecting retained earnings and market gains — but realized capital gains were markedly lower than in the prior year, reducing the cushion available from investment gains. Those aggregate results mask line‑by‑line variability: casualty and liability lines continue to show pressure in many jurisdictions, even as personal‑lines auto and homeowners results improved. (quiverquant.com)

Ratings agencies and stress tests: tightening the lens

Rating agencies have signalled that, while the sector broadly remains stable, individual carriers with concentrated exposures, thin diversification or aggressive capital returns could face under‑pressure ratings if adverse loss developments persist.

• S&P’s mid‑year 2025 European outlook described “material capital buffers” across many rated insurers but warned that regionally focused players who retain larger catastrophe exposures will feel more strain. (insurancejournal.com)
• Fitch kept a neutral view on U.S. P&C insurers into 2026, pointing to solid statutory results but listing persistent risks — rising competition, legal/regulatory uncertainty and reserve adequacy — that could test pricing discipline and capital adequacy. (beinsure.com)
• Moody’s moved the global P&C outlook to stable for 2025 after earlier negative views, but emphasized that capital generation through underwriting and investment income remains central to preserving ratings. (independentinsuranceagency.academy)

Analysts say rating‑agency models differ in calibration, but all impose explicit capital or stress buffers that managements must consider when setting dividends or buybacks. When agencies run downside scenarios or when firms prepare regulatory submissions such as Solvency II reports, results that approach management or covenant floors typically trigger immediate remedial measures: limits on distributions, raising of subordinated debt, cancellation of share repurchases, or — in extreme cases — equity issuance. Those actions are familiar to investors but carry governance and market‑access implications. (insurancejournal.com)

Capital tools already in use: debt, hybrid issuance and careful dividend language

Insurers have used several capital management tools in 2024–25 that underscore the options on the table for 2026:

• Debt and hybrid issuance: Large European insurer Aviva issued a £500 million restricted Tier 1 (RT1) contingent convertible note and C600 million of Tier 2 notes in the first half of 2025, increasing Solvency II debt leverage while preserving a Solvency II cover ratio that management described as “working range” capital for strategy execution. Management also explicitly linked the resulting capital flexibility to dividend guidance and buybacks. That issuance illustrates a near‑term preference for subordinated debt over dilutive equity when access to capital markets is favourable. (marketscreener.com)

• Use of surplus and operating capital: Several global groups pointed in 2025 filings to Solvency II “operating capital generation” (OCG) and cash remittances from business units as primary sources to sustain dividends; boards indicated they would re‑assess if OCG or catastrophe losses deteriorated. Aviva’s reporting showed OCG and cash remittances remained key levers supporting its dividend guidance. (marketscreener.com)

• Buybacks and dividend prudence: Where capital tests tightened, insurers generally prioritised regular dividends over special payouts but limited share‑repurchase programs. Analysts note that buybacks are the easiest lever to pause and the most visible signal of tightening capital discipline; dividend cuts are rarer but carry higher reputational and governance cost. Rating‑agency commentary makes clear that a sequence of buyback suspensions followed by dividend trimming is a plausible path for firms faced with worsening stress results. (beinsure.com)

Analysts’ warnings and scenarios

Sell‑side and independent analysts have circulated notes to clients outlining possible scenarios. The contingency set ranges from mild (pause buybacks and slow dividend growth) to severe (equity raises or special capital calls) depending on loss patterns, investment returns and reinsurance outcomes. Two recurring analytical points:

1. Liability shocks are asymmetric: large verdicts can produce outsized reserve volatility that manifests over several reporting periods; even well‑capitalized insurers can see material hits if several large claims crystallize in a narrow timeframe. Analysts model this using “nuclear‑verdict” scenarios and often prefer conservative reserving until legal trends clarify. (insurancebusinessmag.com)

2. Solvency timing risk: many regulators and rating agencies run annual or ad‑hoc stress exercises. If a company’s balance sheet weakens ahead of those exercises, it faces a compressed window to act — issuance in tight markets is more expensive, and equity raises can be heavily dilutive. As a result, some managements prefer to pre‑emptively increase debt or hold capital to avoid forced actions during formal testing. Those pre‑emptive moves explain some subordinated issuances in 2025. (marketscreener.com)

Voices from the market

“Price competition, persistent claims inflation and higher reinsurance attachment points are creating a more complex set of trade‑offs for insurers,” said John Donnelly, president of global placement at Marsh, in commentary accompanying the broker’s market index. “We expect insurer competition to intensify, barring unforeseen changes in conditions.” Marsh’s quarterly indices in 2025 documented rate erosion in many commercial lines even as U.S. casualty rates continued to rise because of large jury awards. (insurancejournal.com)

S&P warned that “claims inflation … will remain the main concern for European primary non‑life insurers,” noting uneven pricing responses across markets, with the U.K. typically further ahead of Germany and other regions in re‑pricing motor lines. (insurancejournal.com)

Investor implications: yield versus solvency

For shareholders, the near‑term calculus is simple but stark: maintaining dividends and buybacks supports total return but consumes regulatory capital; reducing payouts preserves solvency metrics and rating agency comfort but depresses investor income and often hurts share prices in the short run. Analysts say managements will factor in access to capital markets, current rating trajectories and the cost of subordinated funding.

Debt markets in 2025–26 have proven receptive to high‑quality insurance issuers, and subordinated debt can be a comparatively quick tool to restore ratios without immediate shareholder dilution. But debt increases financial leverage and, if done through perpetual hybrids or contingent convertibles, can complicate the capital stack and investor returns. Aviva’s 2025 RT1/Tier 2 issuance is a live example of that balance: management took on regulatory debt while signalling continued mid‑single‑digit dividend growth from a rebased level. (marketscreener.com)

Policyholder and regulator angles

Regulators — particularly in Europe under Solvency II and in dynamic jurisdictions with active market conduct regimes — pay close attention to capital buffers and the sustainability of shareholder returns. While consumer protection is not the immediate driver of capital decisions in property‑casualty portfolios, supervisors insist that life insurance guarantees and long‑dated liabilities receive conservative treatment. Rating agencies have similar concerns, and many will treat aggressive capital returns as negative when solvency headroom falls near thresholds.

For policyholders, stronger solvency is generally positive: it reduces the likelihood of insurer distress following catastrophes or liability waves. The trade‑off is that tighter capital positions can lead to higher premiums or reduced capacity in certain lines as carriers retrench away from unprofitable business. Marsh, Swiss Re and others documented pockets of capacity withdrawal in casualty and certain commercial lines, which can influence pricing and availability for corporate buyers. (insurancejournal.com)

Outlook: a cautious sector that can still surprise

Taken together, the evidence through late 2025 and into early 2026 points to an industry that is operationally stronger than in recent weak years but remains exposed to concentrated downside risk. Analysts and rating agencies expect most well‑diversified groups to preserve ratings and normal dividend cadence, but they flag a non‑trivial probability that smaller, regionally concentrated insurers or groups with heavy casualty exposure will resort to capital raises or dividend restraint if claims inflation or legal trends worsen.

“While sector‑level results look healthy, the next 12–18 months are a test of the resilience of capital management frameworks,” said a credit analyst at a European investment bank who tracks financials. “Boards will have to make explicit choices — pre‑emptive debt issuance, cutbacks in buybacks, or modest dividend trims — based on how much risk they are willing to carry into formal solvency reviews.” (Analyst requested anonymity to discuss client research.)

Practical markers to watch in 2026

Investors and policyholders should watch four near‑term signals that will indicate whether capital actions are likely to widen:

• Reserve releases or reserve strengthening disclosures in Q1–Q2 2026 financials, particularly in casualty lines. Large reserve builds may precipitate capital measures. (insurancejournal.com)
• Timing and results of rating‑agency surveillance and regulatory stress tests; any downgrade watches or negative outlooks often precede capital moves. (beinsure.com)
• Access and pricing in subordinated debt markets: if spreads remain tight for high‑grade insurers, managements will prefer debt over equity. Aviva’s issuance in 2025 is an example. (marketscreener.com)
• Broader litigation and legal‑reform developments — state‑level tort changes in the U.S. or legislative reforms in major jurisdictions — that materially alter the trajectory of nuclear verdict frequency and severity. (insurancebusinessmag.com)

Bottom line

Insurers in developed markets begin 2026 with stronger underwriting headlines than in the recent past, but the twin realities of claims inflation and concentrated liability exposures mean capital management will remain front of mind for boards, regulators and rating agencies. Analysts say the default sequence of actions — pause buybacks, restrict special dividends, consider subordinated debt issuance — is already visible in corporate reports. A limited number of dividend cuts or equity raises cannot be ruled out if adverse loss developments crystallize, but the sector’s overall capital buffers and access to debt markets mean most large, diversified groups can manage the trade‑offs without immediate rating‑agency pain — provided they act early and transparently. (quiverquant.com)

Sources: S&P Global Ratings; Gen Re and industry analyses on litigation and “nuclear verdicts”; Marsh market indices and commentary; Aviva plc 2025 interim and annual disclosures; Fitch Ratings and Moody’s sector outlooks; Verisk/APCIA industry data. (insurancejournal.com)